TY  - JOUR
AU  - Kenet, Gili
AU  - Chen, Yeu-Chin
AU  - Lowe, Gillian
AU  - Percy, Charles
AU  - Tran, Huyen
AU  - von Drygalski, Annette
AU  - Trossaert, Marc
AU  - Reding, Mark
AU  - Oldenburg, Johannes
AU  - Mingot-Castellano, Maria Eva
AU  - Park, Young-Shil
AU  - Peyvandi, Flora
AU  - Ozelo, Margareth C.
AU  - Mahlangu, Johnny
AU  - Quinn, Jennifer
AU  - Huang, Mei
AU  - Reddy, Divya B.
AU  - Kim, Benjamin
PY  - 2021
DO  - 10.3390/jcm10245959
UR  - https://hdl.handle.net/10668/24435
T2  - Journal of clinical medicine
AB  - Regular prophylaxis with exogenous factor VIII (FVIII) is recommended for individuals with severe haemophilia A (HA), but standardised data are scarce. Here, we report real-world data from a global cohort. Participants were men >= 18 years old with...
LA  - en
PB  - Mdpi
KW  - haemophilia A
KW  - noninterventional study
KW  - FVIII prophylaxis
KW  - On-demand
KW  - Adults
KW  - Euroqol
KW  - Africa
KW  - Safety
KW  - Care
TI  - Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
TY  - research article
VL  - 10
ER  -